SCLX
Scilex Holding CompanyNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$48.53M
P/E Ratio
—
EPS
$-36.48
Beta
1.42
52W High
$34.27
52W Low
$3.92
50-Day MA
$7.50
200-Day MA
$14.01
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.66
PEG Ratio
—
About Scilex Holding Company
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company is headquartered in Palo Alto, California.
Fundamentals
| Revenue (TTM) | $30.25M |
| Gross Profit (TTM) | $19.65M |
| EBITDA | $-267.68M |
| Operating Margin | -782.00% |
| Return on Equity | 0.00% |
| Return on Assets | -74.30% |
| Revenue/Share (TTM) | $2.74 |
| Book Value | $-29.75 |
| Price-to-Book | 28.85 |
| Price-to-Sales (TTM) | 1.60 |
| EV/Revenue | 5.34 |
| EV/EBITDA | -2.64 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -67.80% |
| Shares Outstanding | $7.03M |
| Float | $4.71M |
| % Insiders | 17.56% |
| % Institutions | 13.45% |
Historical Volatility
HV 10-Day
121.11%
HV 20-Day
110.47%
HV 30-Day
100.25%
HV 60-Day
84.94%
HV Rank
36.5%
Volatility is currently expanding
Data last updated: 4/29/2026